Loading clinical trials...
Loading clinical trials...
COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life (NAPKON-POP)
Conditions
Interventions
Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
Locations
3
Germany
University Hospital Wuerzburg
Würzburg, Bavaria, Germany
University Hospital Schleswig-Holstein, Campus Kiel
Kiel, Schleswig-Holstein, Germany
University Hospital Charité Berlin
Berlin, Germany
Start Date
November 16, 2020
Primary Completion Date
December 31, 2021
Completion Date
December 31, 2030
Last Updated
December 22, 2020
NCT07221162
NCT06082518
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
University Hospital Schleswig-Holstein
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions